|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
18
|
|
pubmed:dateCreated |
2003-5-1
|
|
pubmed:abstractText |
Vasodilators are considered to be contraindicated in patients with severe aortic stenosis because of concern that they may precipitate life-threatening hypotension. However, vasodilators such as nitroprusside may improve myocardial performance if peripheral vasoconstriction is contributing to afterload.
|
|
pubmed:commentsCorrections |
|
|
pubmed:keyword |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2003 Massachusetts Medical Society
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
348
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1756-63
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12724481-Aged,
pubmed-meshheading:12724481-Aortic Valve,
pubmed-meshheading:12724481-Aortic Valve Stenosis,
pubmed-meshheading:12724481-Critical Illness,
pubmed-meshheading:12724481-Female,
pubmed-meshheading:12724481-Heart Failure,
pubmed-meshheading:12724481-Hemodynamics,
pubmed-meshheading:12724481-Humans,
pubmed-meshheading:12724481-Male,
pubmed-meshheading:12724481-Nitroprusside,
pubmed-meshheading:12724481-Pressure,
pubmed-meshheading:12724481-Prospective Studies,
pubmed-meshheading:12724481-Stroke Volume,
pubmed-meshheading:12724481-Vasodilator Agents,
pubmed-meshheading:12724481-Ventricular Dysfunction, Left
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis.
|
|
pubmed:affiliation |
Indiana Heart Physicians, Indianapolis 46107, USA. khot@cvresearch.net
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
